Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,779.00
Bid: 1,765.00
Ask: 1,782.00
Change: 26.00 (1.48%)
Spread: 17.00 (0.963%)
Open: 1,779.00
High: 1,779.00
Low: 1,779.00
Prev. Close: 1,753.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

12 Jan 2021 07:00

RNS Number : 3146L
Johnson Matthey PLC
12 January 2021
 

 

Johnson Matthey appoints Stephen Oxley as Chief Financial Officer

 

Johnson Matthey is pleased to announce that Stephen Oxley will join the company's board on 1st April 2021 as Chief Financial Officer (CFO). On the same date, Karen Hayzen-Smith will step down as interim CFO and continue in her role as Group Financial Controller.

 

Stephen joins us from KPMG, where he is a Partner. He brings experience of both audit and advisory roles for large, complex, international companies across a variety of sectors, including FMCG, healthcare, natural resources and industrials. He has worked with major global FTSE 100 and private companies, including Johnson Matthey. In addition to his operational and technical understanding of JM, Stephen also brings significant experience working with companies going through major change programmes.

 

In his current role, Stephen also leads KPMG UK's dialogue with the investor community on areas including performance, stewardship, climate change and Environment, Social and Governance (ESG) matters.

 

Stephen is a qualified chartered accountant and has worked at KPMG for almost 30 years. He is a trustee of Care International UK and chairs its finance and audit committee.

 

Commenting on Stephen's appointment, Robert MacLeod, Chief Executive of Johnson Matthey said:

 

"I am extremely pleased that Stephen will join JM in April, and I am looking forward to working with him. I would also like to thank Karen for her valuable contributions and ongoing support over the past few months.

 

Stephen's extensive experience in working with large global companies on major strategic programmes will enable him to make an immediate contribution to JM as we progress our transformation and deliver our growth opportunities to create a cleaner, healthier world."

 

Stephen Oxley said: "I am delighted to be joining JM at such an exciting time. The company's sustainable technologies are right at the heart of tackling climate change and I am looking forward to working with Robert and the rest of the executive team to deliver the strategy and create value for all our stakeholders."

 

Stephen's remuneration will be in line with Johnson Matthey's Directors' Remuneration Policy as set out in our Annual Report.

 

There is no information to be disclosed pursuant to Rule 9.6.13 of the Listing Rules.

 

Enquiries: 

 

 

 

Investor Relations

Martin Dunwoodie

Louise Curran

Jane Crosby

 

 

Director of Investor Relations

Senior Investor Relations Manager

Investor Relations Manager

 

 

020 7269 8241

020 7269 8235

020 7269 8242

 

 

Media

Sally Jones

Simon Pilkington

 

 

 

Director of Corporate Relations

Tulchan Communications

 

 

 

020 7269 8407

020 7353 4200

  

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMMRMKGMZM
Date   Source Headline
18th Apr 20245:33 pmRNSDirector/PDMR Shareholding
17th Apr 20243:07 pmRNSHolding(s) in Company
10th Apr 20243:10 pmRNSHolding(s) in Company
10th Apr 20249:47 amRNSHolding(s) in Company
9th Apr 20249:00 amRNSHolding(s) in Company
8th Apr 20249:00 amRNSHolding(s) in Company
3rd Apr 20245:16 pmRNSHolding(s) in Company
2nd Apr 20249:01 amRNSHolding(s) in Company
2nd Apr 20249:00 amRNSHolding(s) in Company
27th Mar 20241:46 pmRNSHolding(s) in Company
22nd Mar 20243:11 pmRNSHolding(s) in Company
21st Mar 202412:13 pmRNSDirector/PDMR Shareholding
20th Mar 20247:00 amRNSJohnson Matthey sale of Medical Device Components
18th Mar 20243:05 pmRNSHolding(s) in Company
18th Mar 20242:32 pmRNSHolding(s) in Company
12th Mar 20245:12 pmRNSHolding(s) in Company
12th Mar 20249:00 amRNSHolding(s) in Company
11th Mar 20249:00 amRNSHolding(s) in Company
7th Mar 20244:20 pmRNSHolding(s) in Company
22nd Feb 20244:53 pmRNSDirector/PDMR Shareholding
20th Feb 20243:57 pmRNSHolding(s) in Company
19th Feb 20243:12 pmRNSHolding(s) in Company
15th Feb 20249:54 amRNSDirector/PDMR Shareholding
9th Feb 20244:17 pmRNSHolding(s) in Company
9th Feb 202412:31 pmRNSDirector/PDMR Shareholding
8th Feb 20242:17 pmRNSHolding(s) in Company
1st Feb 20244:08 pmRNSHolding(s) in Company
29th Jan 20243:22 pmRNSHolding(s) in Company
29th Jan 20242:37 pmRNSHolding(s) in Company
29th Jan 20242:35 pmRNSHolding(s) in Company
23rd Jan 20244:47 pmRNSHolding(s) in Company
19th Jan 20242:18 pmRNSHolding(s) in Company
18th Jan 20242:30 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSDirector/PDMR Shareholding
10th Jan 20241:29 pmRNSHolding(s) in Company
9th Jan 20241:31 pmRNSHolding(s) in Company
5th Jan 20244:50 pmRNSHolding(s) in Company
4th Jan 20244:26 pmRNSHolding(s) in Company
2nd Jan 20243:27 pmRNSHolding(s) in Company
28th Dec 20231:35 pmRNSHolding(s) in Company
21st Dec 20231:25 pmRNSDirector/PDMR Shareholding
19th Dec 20232:29 pmRNSHolding(s) in Company
15th Dec 20239:00 amRNSHolding(s) in Company
13th Dec 20233:01 pmRNSHolding(s) in Company
11th Dec 20234:20 pmRNSHolding(s) in Company
7th Dec 20231:41 pmRNSHolding(s) in Company
6th Dec 20231:52 pmRNSHolding(s) in Company
6th Dec 202312:00 pmRNSDirector/PDMR Shareholding
5th Dec 20232:56 pmRNSHolding(s) in Company
1st Dec 20233:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.